Wuhan Weke Medical Co-Founder and CTO Chen Song Selected for Hubei Province's 'Chutian Talents Plan – Outstanding Engineer Program'

Recently, the Symposium on the Reform of Outstanding Engineer Training was held in Beijing. Ding Xuexiang, member of the Standing Committee of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, attended the meeting and pointed out that engineers are the main innovative force driving the development of engineering technology and an important part of the national strategic talent pool. The meeting once again emphasized an important instruction from General Secretary Xi Jinping: to increase the independent training of engineering and technical personnel and accelerate the construction of a large-scale team of outstanding engineers.

The Talent Work Leading Group Office of the Hubei Provincial Party Committee has recently officially announced the list of selected personnel for the 2025 "Chu Tian Yingcai Plan · Outstanding Engineer Project."Mr. Chen Song, Co-founder and CTO of Wuhan Vickor Medical Technology Co., Ltd., has been successfully selected for his profound technical expertise, outstanding innovative achievements, and significant contributions to the industry.

"The Chutian Elite Plan · Outstanding Engineer Project" is led by the Hubei Provincial Party Committee's Talent Work Leading Group and jointly implemented by multiple departments, including the Provincial Party Committee's Civil-Military Integration Office, the Provincial Department of Education, the Provincial Department of Science and Technology, the Provincial Department of Economy and Information Technology, the Provincial Health Commission, and the Provincial Government's State-owned Assets Supervision and Administration Commission. It is an important measure to advance the talent-strengthening strategy of Hubei Province.

The project focuses on strengthening the "51020" advanced manufacturing cluster and building a modern industrial system that reflects Hubei's advantages.Focus on cultivating a group of industrial talents with outstanding technological innovation capabilities, adept at solving complex engineering problems, and able to break through urgently needed technologies in the industry., to enhance independent innovation capabilities through the research of key engineering technology projects, and lay a solid talent foundation for Hubei to accelerate the construction of an important strategic fulcrum for the rise of the central region.

Mr. Chen Song has深耕 the field of cardiovascular interventional devices for seventeen years, always致力于 product design and technological innovation, achieving a series of breakthrough results,ParticipateDeveloped the first generation of China's domestic congenital heart disease occlusion system, with a market share leading in China; In 2018, after co-founding Vickor, led the R&D team to successively develop more than ten innovative medical devices such as atrial shunt devices.

With a composite background in biomedical engineering and EMBA, Mr. Chen Song successfully tackled industry challenges such as endothelialization of interventional devices and metal fatigue through breakthroughs like the design of unilateral eccentric rivets. The atrial shunt technology he led in developing obtained dual certifications from China and the U.S., reaching an internationally leading level. He has successively...Led participation in 5 national-level scientific research projects, obtained authorization for over 100 patents (including 80 invention patents), published 6 SCI papers, led the formulation of 5 corporate standards, and continuously promoted technological iteration and product upgrades.

Under the joint leadership of Mr. Chen Song and other co-founders, Vickor has established a "medical-research-enterprise" collaborative innovation model, partnering with dozens of clinical centers across China to develop and conduct clinical trials for more than ten core products. In 2024, the revenue from the launch of the patent foramen ovale occluder reached tens of millions, and the aortic valve replacement system was selected as a national key project. He has successively won top global innovation certifications and design awards, including the German Red Dot Award, the Special Prize of Hubei Province Science and Technology Progress Award, and one of the top ten innovative achievements in medical-engineering integration in Hubei Province.

Vickor, with its continuous innovation capabilities and outstanding product design, has become a potential unicorn enterprise in China. Over the past six years, it has accumulated financing of more than 400 million yuan, with a valuation reaching 2 billion yuan. It has repeatedly received national-level honors, injecting strong momentum into the technological advancement and industrial development in the field of cardiovascular intervention.

This selection,This is not only a high recognition of Mr. Chen Song's personal outstanding technical capabilities and industry contributions but also a full affirmation of Vickor's commitment to technological innovation and its strategic focus on cultivating talent in specialized fields.In the future, Vickor will continue to deepen its strategy of strengthening the company through talent and technological innovation, increase efforts in talent cultivation, build a broader innovation platform, and contribute more to the high-quality development of the medical device industry and the construction of Hubei as a talent-strong province.